EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Subacute Thyroiditis Following Third Dose of Pfizer-BioNTech COVID-19 (mRNA) Vaccine in a Patient with Clear Cell Renal Cell Carcinoma: A Case Report

Amro Nagy, Muhammad Yaqut, Doaa Abbas, Amna Mohamed

Oman Medical Journal · 2026-07-31 · 41 (4) · e864-e864

DOI: 10.5001/omj.2026.10 ↗
AbstractBibliografische Angaben

Abstract

Over 160 cases of subacute thyroiditis (SAT) following COVID-19 vaccination or infection have been reported in the literature. Roughly one-half were attributed to either the first or second dose of the COVID-19 vaccine. We report a rare case of SAT in a 47-year-old male patient with a history of clear cell renal cell carcinoma and advanced chronic kidney disease, among other comorbidities, excluding thyroid disease. After he received the third dose of the Pfizer mRNA vaccine, a deranged thyroid profile was accidentally discovered. His SAT remained asymptomatic and normalized in about six months without treatment. SAT post-COVID vaccination is a self-limiting and rare condition that should be considered in the differential diagnosis of silent thyroiditis.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →